Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and n Read more about Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and n
Progress against GI cancer during the American Society of Clinical Oncology's first 50 years. Read more about Progress against GI cancer during the American Society of Clinical Oncology's first 50 years.
Phase I dose-escalation study of 5-day intermittent oral lapatinib therapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer. Read more about Phase I dose-escalation study of 5-day intermittent oral lapatinib therapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer.
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database. Read more about Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database.
American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes. Read more about American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes.
The end of the beginning: circulating tumor cells as a biomarker in castration-resistant prostate cancer. Read more about The end of the beginning: circulating tumor cells as a biomarker in castration-resistant prostate cancer.
Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance). Read more about Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance).
Curable patient with metastatic colorectal cancer: balancing effective therapies and toxicities. Read more about Curable patient with metastatic colorectal cancer: balancing effective therapies and toxicities.
Cytogenetic prognostication within medulloblastoma subgroups. Read more about Cytogenetic prognostication within medulloblastoma subgroups.
